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Recent advances in technology have opened up the pos-
sibility of using next generation sequencing to efficiently
uncover predisposing mutations in individuals with
inherited cancer in an unbiased manner. We are con-
ducting whole exome sequence analysis of germline
DNA from multiple affected relatives from breast cancer
families with the aim of identifying rare protein truncat-
ing and non-synonymous variants that are likely to
include novel cancer predisposing mutations. Data from
>70 exomes show that on average each individual only
carries 30-50 protein truncating mutations and 300-400
rare non-synonymous missense variants. By considering
only those variants shared by multiple affected relatives
the number of candidate predisposing mutations can be
dramatically reduced to just 3-5 truncating mutations
and 10-20 nonsynonymous variants per family. Among
the first 10 breast cancer families studied in detail, two
harbour mutations in known breast cancer genes that
were missed by clinical genetic testing either because
the index case was a phenocopy who did not carry the
mutation (BRCA2) or because the gene is not routinely
tested in the context of breast cancer without additional
clinical manifestations (PTEN). Among the remaining
families candidate genes are currently being assessed for
segregation among family members and for prevalence
among an addition 800+ unexplained breast cancer
families. In particular, we found truncating mutations in
two genes that are involved in well-recognised DNA
repair pathways but have not previously been associated
with an increased risk of breast cancer. In summary,
whole exome sequencing of multiple individuals from
within each cancer family is proving to be an efficient
strategy for rapidly identifying novel familial predispos-
ing mutations.
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